Clin2
NCT06934811Possibly a fitNot yet recruiting

Sedative ciprofol for ECMO patients

ECMO TreatmentARDS (Acute Respiratory Distress Syndrome)ECMO and Acute MIRespiratory Failure Patients Treated With ECMOShock, Cardiogenic

Treatments studied

Part of Heart & circulation, Lungs & breathing clinical trials.

This study tests a new sedative called ciprofol to see if it helps the oxygenator (the part of the ECMO machine that adds oxygen to your blood) work better. If you are already on ECMO and need sedation, this trial might help improve your treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
30 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must currently be on ECMO (a machine that helps your heart and lungs work) and expected to stay on it for more than 3 days.
  • You must be on a breathing machine (ventilator) to help you breathe.
  • You must need medication to keep you calm and comfortable (sedation and pain relief).
  • You must be 18 years or older.
  • You must not have severe liver or kidney failure, severe mental health conditions, or be pregnant.
  • You must not have any allergies to common sedatives like midazolam or propofol.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07536750Recruiting
Comparing Two Sedation Drugs for ICU Patients on Breathing Support

This study compares two medications (ciprofol and propofol) used to keep ICU patients calm and comfortable while they receive non-invasive breathing support, such as oxygen masks or tubes that help them breathe without a breathing tube in their windpipe. Researchers want to see which drug works better and is safer.

Guangzhou, Guangdong
NCT07670923Recruiting· Phase 4
Comparing two sedatives for older patients during non-intubated surgery

This trial compares two sedative medicines, ciprofol and propofol, to see which works better for older patients having surgery without a breathing tube. It aims to find the safer option for your heart and lungs.

Yinchuan, Ningxia
NCT07099014Not yet recruiting· Phase 3
Inhaled isoflurane for sedation during ECMO for heart shock

This study tests an inhaled sedative called isoflurane to keep patients calm while on a breathing machine and ECMO for severe heart failure. It may be an alternative to standard IV sedatives.

NCT07028593Recruiting· Phase 4
Ciprofol for heart protection during lung surgery

This trial tests if a new sedative drug, Ciprofol, can reduce heart damage after non-cardiac surgery compared to standard care. It is for people aged 45–80 having planned lung surgery (like lobe removal or wedge resection) who will stay in the hospital for at least 3 days after the procedure.

Wuhan
NCT07376577Recruiting
Sedation for older adults having ERCP

This trial tests a combination of two sedatives (anricofen and ciprofol) for deep sedation in older adults having an ERCP procedure. It aims to see if this combination is safe and effective for patients between 60 and 90 years old with mild to moderate health conditions.

Xinxiang, Henan
NCT06952608Recruiting· Phase 4
Ciprofol for blood pressure stability in older adults on heart medications

This study tests whether ciprofol, a newer sedative, can help prevent low blood pressure during surgery in older patients who are already taking medications for high blood pressure or heart failure (called RAS inhibitors). It may be a good option if you're 65 or older, on these medications for more than 3 months, and having abdominal surgery lasting over 2 hours.

Hangzhou, Zhejiang

Hear when a new ECMO Treatment trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.